Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An open-label, multi-center, phase I/II study of ECI830 as a single agent and in combination with ribociclib and endocrine therapy in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors
White, M. (Primary Chief Investigator (PCI)) & Day, D. (Chief Investigator (CI))
24/04/25 → 23/04/30
Project: Research
-
A Phase 1a/b, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG‑C137, an Antibody-Drug Conjugate Targeting FGFR2b, in Patients With Advanced Solid Tumors
Day, D. (Primary Chief Investigator (PCI)) & Body, A. (Chief Investigator (CI))
7/11/24 → 6/11/29
Project: Research
-
A Phase 1a/1b Study of BG-68501, a Selective CDK2 Inhibitor, in Participants With Advanced Solid Tumors
Frentzas, S. (Primary Chief Investigator (PCI)), Day, D. (Primary Chief Investigator (PCI)) & Day, D. (Primary Chief Investigator (PCI))
1/05/24 → 30/04/29
Project: Research
-
A Multicentre, Open-label, Phase 1/2 Study of IBI133 in Subjects with Unresectable, Locally Advanced or Metastatic Solid Tumours
Body, A. (Primary Chief Investigator (PCI)) & Day, D. (Primary Chief Investigator (PCI))
27/03/24 → 26/03/29
Project: Research
-
A Phase 1, Multicenter, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of DCSZ11 as a Monotherapy and in Combination in Patients with Advanced or Metastatic Solid Tumors
Day, D. (Primary Chief Investigator (PCI)) & Frentzas, S. (Chief Investigator (CI))
15/03/24 → 14/03/29
Project: Research
-
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Blennerhassett, R., Hamad, N., Grech, L., Kwok, A., Choi, T., Forsyth, C., Jagger, J., Opat, S., Harris, S., Chan, B. A., Nguyen, M., Bain, N., Day, D., Segelov, E. & on behalf of the CANVACCS Investigators, Sept 2024, In: Acta Haematologica. 147, 5, p. 543-554 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter
Tan, S., Kader, Z., Day, D., Chen, D., Nicholls, S. J. & Ramkumar, S., May 2024, In: Heart Lung and Circulation. 33, 5, p. 553-557 5 p.Research output: Contribution to journal › Editorial › Other › peer-review
2 Citations (Scopus) -
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia
Wang, H., Grech, L., Wong, J., Hoffman, D., de Courten, B., Sillars, B., Savage, M., Kwok, A., Nguyen, M., Bain, N., Day, D., Segelov, E. & on behalf of the DIABVACCS Investigators, Jun 2024, In: Vaccines. 12, 6, 16 p., 662.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
Choi, T. S. T., Chan, B., Grech, L. B., Kwok, A., Webber, K., Wong, J. L. A., Nguyen, M., Bain, N., Day, D., McCartney, A., Hamer, R., Segelov, E. & on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators, Feb 2023, In: Vaccines. 11, 2, 17 p., 239.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial
Day, D., Toh, H. C., Ali, R., Foo, E. M. J., Simes, J., Chia, J. W. K., Segelov, E. & on behalf of the ASCOLT Investigators, 1 Jun 2023, In: JCO Global Oncology. 9, p. 1-10 10 p., e2300040.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus)
Press/Media
-
National study informs COVID-19 vaccine hesitancy in people with cancer
Segelov, E., Grech, L., Day, D., Nguyen, M. & Bain, N.
21/06/22
1 item of Media coverage
Press/Media: Article/Feature